Eargo, Inc.


Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, is investigating whether Eargo, Inc. (“Eargo” or the “Company”) (NASDAQ: EAR) and certain of its officers and directors violated federal securities laws by making materially misleading statements to investors.  If you purchased or otherwise own Eargo stock, and have suffered a loss, you are encouraged to contact attorney Rhiana Swartz at (844) 818-6980 for more information. 

Eargo is a medical device company focused on hearing loss.   

On September 22, 2021, after the close of trading, Eargo disclosed that it is the target of a criminal investigation by the U.S. Department of Justice (DOJ) related to insurance reimbursement claims that the Company has submitted on behalf of its customers covered by federal employee health plans.  Eargo also announced it is withdrawing its financial guidance for the fiscal year ending December 31, 2021. 

On this news, Eargo shares dropped more than 68% on September 23, 2021, to close at a price of $6.86, down from its previous close price of $21.67. 

What You Can Do 

If you purchased or otherwise own Eargo stock, and you wish to discuss this investigation, please contact attorney Rhiana Swartz at (844) 818-6980, or at rswartz@scott-scott.com. 

About Scott+Scott Attorneys at Law LLP 

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States.  The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, Virginia, California, and Ohio. 

Attorney Advertising 

CONTACT: 

Rhiana Swartz 

Scott+Scott Attorneys at Law LLP 

230 Park Ave, 17th Fl, NY, NY 10169 

(844) 818-6980 

rswartz@scott-scott.com  

Tags:

Securities